Paediatric formulation of fosamprenavir approved in Europe

2 October 2007. Related: Antiretrovirals.

On 13 September, the EMEA issued a decision to extend the indication for fosamprenavir (Telzir) in combination with ritonavir to include adolescents and children of six years and older.

Telzir – EMEA European Public Assessment Report (includes full prescribing information)
http://www.emea.europa.eu/humandocs/Humans/EPAR/telzir/telzir.htm
Telzir – EMEA scientific opinion for approval PDF
http://www.emea.europa.eu/humandocs/PDFs/EPAR/telzir/EMEA-H-534-II-18-AR.pdf

Source: GSK press release.